Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LRRK2 anticorps (AA 878-909)

LRRK2 Reactivité: Humain, Souris WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN3031607
  • Antigène Voir toutes LRRK2 Anticorps
    LRRK2 (Leucine-Rich Repeat Kinase 2 (LRRK2))
    Épitope
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 878-909
    Reactivité
    • 20
    • 7
    • 1
    Humain, Souris
    Hôte
    • 17
    • 3
    Lapin
    Clonalité
    • 16
    • 4
    Polyclonal
    Conjugué
    • 17
    • 1
    • 1
    • 1
    Cet anticorp LRRK2 est non-conjugé
    Application
    • 14
    • 8
    • 7
    • 5
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Purification
    Antigen affinity purified
    Immunogène
    A portion of amino acids 878-909 from the human protein was used as the immunogen for this LRRK2 antibody.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product LRRK2 Anticorps primaire
  • Indications d'application
    Titration of the LRRK2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,IHC (Paraffin): 1:10-1:50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In 1X PBS, pH 7.4, with 0.09 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Aliquot the LRRK2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
  • Antigène
    LRRK2 (Leucine-Rich Repeat Kinase 2 (LRRK2))
    Autre désignation
    LRRK2 (LRRK2 Produits)
    Sujet
    Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson's disease identified to date. LRRK2, a genetic mutation, was recently found linked to about 5 percent of inherited cases of Parkinson's disease. By high-resolution recombination mapping and candidate gene sequencing in 46 families, 6 disease-segregating mutations (5 missense and 1 putative splice site mutation). It may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism. LRRK2 belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.
    UniProt
    Q5S007
    Pathways
    Regulation of G-Protein Coupled Receptor Protein Signaling, Skeletal Muscle Fiber Development
Vous êtes ici:
Support technique